Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...

Geneticist Nilabja Sikdar in Calcutta, with collaborators in Jadavpur University, Israel and the US, has found that patients ...

Seven warning signs of pancreatic cancer you shouldn't ignore as these subtle symptoms often get dismissed but could save ...

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Dr. Anandhan's research marks a significant step forward in the fight against pancreatic cancer, offering renewed hope for ...

We also found that tumors release a protein called Activin-A, which acts on blood vessels to cause the leakiness and, ultimately, loss of blood vessels in the muscle. When we used a gene therapy to ...

PanTher Therapeutics today announced that the first patient has been treated with PTM-101 in a Phase 1b trial in pancreatic ductal adenocarcinoma.

We will use our fast-track status to find the most efficient regulatory path forward this summer to advance our platform in a ...